Logo image of ALLUX.PA

INSTALLUX SA (ALLUX.PA) Stock Fundamental Analysis

Europe - EPA:ALLUX - FR0000060451 - Common Stock

306 EUR
-4 (-1.29%)
Last: 10/6/2025, 7:00:00 PM
Fundamental Rating

5

Overall ALLUX gets a fundamental rating of 5 out of 10. We evaluated ALLUX against 23 industry peers in the Building Products industry. ALLUX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ALLUX is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ALLUX had positive earnings in the past year.
In the past year ALLUX had a positive cash flow from operations.
Each year in the past 5 years ALLUX has been profitable.
Of the past 5 years ALLUX 4 years had a positive operating cash flow.
ALLUX.PA Yearly Net Income VS EBIT VS OCF VS FCFALLUX.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

ALLUX's Return On Assets of 4.62% is in line compared to the rest of the industry. ALLUX outperforms 56.52% of its industry peers.
ALLUX has a Return On Equity of 7.00%. This is comparable to the rest of the industry: ALLUX outperforms 47.83% of its industry peers.
Looking at the Return On Invested Capital, with a value of 5.58%, ALLUX is in line with its industry, outperforming 47.83% of the companies in the same industry.
ALLUX had an Average Return On Invested Capital over the past 3 years of 5.10%. This is significantly below the industry average of 10.74%.
The 3 year average ROIC (5.10%) for ALLUX is below the current ROIC(5.58%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.62%
ROE 7%
ROIC 5.58%
ROA(3y)4.21%
ROA(5y)4.15%
ROE(3y)6.23%
ROE(5y)6.04%
ROIC(3y)5.1%
ROIC(5y)5.26%
ALLUX.PA Yearly ROA, ROE, ROICALLUX.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 5.72%, ALLUX perfoms like the industry average, outperforming 56.52% of the companies in the same industry.
ALLUX's Profit Margin has declined in the last couple of years.
The Operating Margin of ALLUX (7.37%) is comparable to the rest of the industry.
ALLUX's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 33.60%, ALLUX perfoms like the industry average, outperforming 52.17% of the companies in the same industry.
In the last couple of years the Gross Margin of ALLUX has remained more or less at the same level.
Industry RankSector Rank
OM 7.37%
PM (TTM) 5.72%
GM 33.6%
OM growth 3Y-4.42%
OM growth 5Y-4.41%
PM growth 3Y-1.87%
PM growth 5Y-2.59%
GM growth 3Y-0.49%
GM growth 5Y0.54%
ALLUX.PA Yearly Profit, Operating, Gross MarginsALLUX.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALLUX is destroying value.
The number of shares outstanding for ALLUX remains at a similar level compared to 1 year ago.
Compared to 5 years ago, ALLUX has less shares outstanding
ALLUX has a better debt/assets ratio than last year.
ALLUX.PA Yearly Shares OutstandingALLUX.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50K 100K 150K 200K 250K
ALLUX.PA Yearly Total Debt VS Total AssetsALLUX.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 3.22 indicates that ALLUX is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.22, ALLUX is in the better half of the industry, outperforming 78.26% of the companies in the same industry.
The Debt to FCF ratio of ALLUX is 2.09, which is a good value as it means it would take ALLUX, 2.09 years of fcf income to pay off all of its debts.
ALLUX's Debt to FCF ratio of 2.09 is amongst the best of the industry. ALLUX outperforms 82.61% of its industry peers.
ALLUX has a Debt/Equity ratio of 0.17. This is a healthy value indicating a solid balance between debt and equity.
ALLUX's Debt to Equity ratio of 0.17 is amongst the best of the industry. ALLUX outperforms 86.96% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.09
Altman-Z 3.22
ROIC/WACC0.78
WACC7.16%
ALLUX.PA Yearly LT Debt VS Equity VS FCFALLUX.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

2.3 Liquidity

ALLUX has a Current Ratio of 3.04. This indicates that ALLUX is financially healthy and has no problem in meeting its short term obligations.
ALLUX's Current ratio of 3.04 is amongst the best of the industry. ALLUX outperforms 95.65% of its industry peers.
A Quick Ratio of 2.29 indicates that ALLUX has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 2.29, ALLUX belongs to the best of the industry, outperforming 95.65% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.04
Quick Ratio 2.29
ALLUX.PA Yearly Current Assets VS Current LiabilitesALLUX.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.82% over the past year.
ALLUX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.84% yearly.
The Revenue has decreased by -1.33% in the past year.
The Revenue has been growing slightly by 2.06% on average over the past years.
EPS 1Y (TTM)29.82%
EPS 3Y2.59%
EPS 5Y0.84%
EPS Q2Q%-21.15%
Revenue 1Y (TTM)-1.33%
Revenue growth 3Y2.1%
Revenue growth 5Y2.06%
Sales Q2Q%-0.81%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALLUX.PA Yearly Revenue VS EstimatesALLUX.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ALLUX.PA Yearly EPS VS EstimatesALLUX.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 5 10 15 20 25

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.12 indicates a reasonable valuation of ALLUX.
Compared to the rest of the industry, the Price/Earnings ratio of ALLUX indicates a rather cheap valuation: ALLUX is cheaper than 91.30% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of ALLUX to the average of the S&P500 Index (27.76), we can say ALLUX is valued rather cheaply.
Industry RankSector Rank
PE 10.12
Fwd PE N/A
ALLUX.PA Price Earnings VS Forward Price EarningsALLUX.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ALLUX indicates a rather cheap valuation: ALLUX is cheaper than 100.00% of the companies listed in the same industry.
82.61% of the companies in the same industry are more expensive than ALLUX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 5.12
EV/EBITDA 3.46
ALLUX.PA Per share dataALLUX.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300 400 500

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)12.12
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.58%, ALLUX has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.85, ALLUX pays a better dividend. On top of this ALLUX pays more dividend than 82.61% of the companies listed in the same industry.
ALLUX's Dividend Yield is comparable with the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 2.58%

5.2 History

The dividend of ALLUX has a limited annual growth rate of 2.40%.
Dividend Growth(5Y)2.4%
Div Incr Years1
Div Non Decr Years4
ALLUX.PA Yearly Dividends per shareALLUX.PA Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 5 10 15

5.3 Sustainability

26.45% of the earnings are spent on dividend by ALLUX. This is a low number and sustainable payout ratio.
ALLUX's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP26.45%
EPS Next 2YN/A
EPS Next 3YN/A
ALLUX.PA Yearly Income VS Free CF VS DividendALLUX.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M
ALLUX.PA Dividend Payout.ALLUX.PA Dividend Payout, showing the Payout Ratio.ALLUX.PA Dividend Payout.PayoutRetained Earnings

INSTALLUX SA

EPA:ALLUX (10/6/2025, 7:00:00 PM)

306

-4 (-1.29%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryBuilding Products
Earnings (Last)08-04 2025-08-04
Earnings (Next)03-30 2026-03-30
Inst Owners9.28%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap85.68M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.58%
Yearly Dividend7.99
Dividend Growth(5Y)2.4%
DP26.45%
Div Incr Years1
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 10.12
Fwd PE N/A
P/S 0.58
P/FCF 5.12
P/OCF 4.33
P/B 0.71
P/tB 0.78
EV/EBITDA 3.46
EPS(TTM)30.23
EY9.88%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)59.73
FCFY19.52%
OCF(TTM)70.62
OCFY23.08%
SpS527.23
BVpS431
TBVpS392.72
PEG (NY)N/A
PEG (5Y)12.12
Profitability
Industry RankSector Rank
ROA 4.62%
ROE 7%
ROCE 7.52%
ROIC 5.58%
ROICexc 9%
ROICexgc 10.22%
OM 7.37%
PM (TTM) 5.72%
GM 33.6%
FCFM 11.33%
ROA(3y)4.21%
ROA(5y)4.15%
ROE(3y)6.23%
ROE(5y)6.04%
ROIC(3y)5.1%
ROIC(5y)5.26%
ROICexc(3y)7.84%
ROICexc(5y)8.15%
ROICexgc(3y)8.38%
ROICexgc(5y)8.55%
ROCE(3y)6.88%
ROCE(5y)7.1%
ROICexcg growth 3Y-6.46%
ROICexcg growth 5Y-0.4%
ROICexc growth 3Y-9.66%
ROICexc growth 5Y-2.64%
OM growth 3Y-4.42%
OM growth 5Y-4.41%
PM growth 3Y-1.87%
PM growth 5Y-2.59%
GM growth 3Y-0.49%
GM growth 5Y0.54%
F-Score7
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF 2.09
Debt/EBITDA 1.1
Cap/Depr 37.59%
Cap/Sales 2.07%
Interest Coverage 250
Cash Conversion 104.15%
Profit Quality 197.93%
Current Ratio 3.04
Quick Ratio 2.29
Altman-Z 3.22
F-Score7
WACC7.16%
ROIC/WACC0.78
Cap/Depr(3y)48.04%
Cap/Depr(5y)49.49%
Cap/Sales(3y)2.46%
Cap/Sales(5y)2.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.82%
EPS 3Y2.59%
EPS 5Y0.84%
EPS Q2Q%-21.15%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-1.33%
Revenue growth 3Y2.1%
Revenue growth 5Y2.06%
Sales Q2Q%-0.81%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y28.1%
EBIT growth 3Y-2.41%
EBIT growth 5Y-2.44%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-3.9%
FCF growth 3Y-8.2%
FCF growth 5YN/A
OCF growth 1Y-9.76%
OCF growth 3Y-8.83%
OCF growth 5Y21.69%